首页> 外文OA文献 >PND53 Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut Guttmann

【2h】

PND53 Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut Guttmann

机译：在Intitut Guttmann医院进行的非局部致残性痉挛性耐受或不耐受的患者中，鞘内注射巴氯芬治疗与常规药物治疗相比的PTN53成本-效果模型结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Slof J.; Serrano D.; Álvarez M.; Álvarez López-Dóriga M.; Marqués T.; Benito J.; Vidal J.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of Intrathecal Baclofen Therapy in severe refractory non-focal disabling spasticity: a Spanish hospital perspective [J] . Vidal Joan, Slof John, Serrano David, Expert review of pharmacoeconomics & outcomes research . 2017,第1a3期

机译：严重难治性非局灶性痉挛性陷入困难的鞘内Baclofen治疗的成本效果：西班牙医院的观点
2. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity. [J] . Bensmail D, Ward AB, Wissel J, Neurorehabilitation and neural repair . 2009,第6期

机译：鞘内注射巴氯芬治疗与禁用痉挛的其他干预措施的成本效益模型。
3. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS) [J] . Creamer Michael, Cloud Geoffrey, Kossmehl Peter, Journal of Neurology, Neurosurgery and Psychiatry . 2018,第6期

机译：鞘内嗜酸盐疗法对严重失败痉挛的传统医学管理：多期，随机，受控，开放式试验（姐妹）的结果
4. Research paper: Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre randomised controlled open-label trial (SISTERS) [O] . Michael Creamer, Geoffrey Cloud, Peter Kossmehl, -1

机译：研究论文：鞘内注射巴氯芬治疗与常规药物治疗的严重中风后痉挛：一项多中心随机对照开放标签试验（SISTERS）的结果
5. PND34 Clinical Outcomes and Health Care Resource Utilization in a 1-Year Observational Study of Patients with Non-focal Disabling Spasticity who are Resistant or Intolerant to Oral Therapy Treated with Intrathecal Baclofen Therapy at the Institut Guttmann (Spain). Epice Study [O] . Slof J., Serrano D., Álvarez López-Dóriga M., 2014

机译：PND34临床结果和医疗保健资源的利用，在对Guttmann研究所（西班牙）的鞘内巴氯芬疗法进行口服治疗的耐药性或耐受性不佳的非局部致残性痉挛患者的1年观察研究中。香料研究

PND53 Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut Guttmann

著录项

引文网络

相似文献

相关主题

期刊订阅